The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people.
Identifieur interne : 000765 ( PubMed/Curation ); précédent : 000764; suivant : 000766The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people.
Auteurs : L. Shepherd [Royaume-Uni] ; Á H. Borges [Danemark] ; R. Harvey [Royaume-Uni] ; M. Bower [Royaume-Uni] ; A. Grulich [Australie] ; M. Silverberg [États-Unis] ; J. Weber [Royaume-Uni] ; M. Ristola [Finlande] ; J-P Viard [France] ; J R Bogner [Allemagne] ; P. Gargalianos-Kakolyris [Grèce] ; C. Mussini [Italie] ; K. Mansinho [Portugal] ; I. Yust [Israël] ; D. Paduta [Biélorussie] ; D. Jilich [République tchèque] ; T. Smiatacz [Pologne] ; R. Radoi [Roumanie] ; J. Tomazic [Slovénie] ; P. Plomgaard [Danemark] ; R. Frikke-Schmidt [Danemark] ; J. Lundgren [Danemark] ; A. Mocroft [Royaume-Uni]Source :
- HIV medicine [ 1468-1293 ] ; 2017.
Abstract
B-cell dysfunction and activation are thought to contribute to lymphoma development in HIV-positive people; however, the mechanisms are not well understood. We investigated levels of several markers of B-cell dysfunction [free light chain (FLC)-κ, FLC-λ, immunoglobulin G (IgG), IgA, IgM and IgD] prior to lymphoma diagnosis in HIV-positive people.
DOI: 10.1111/hiv.12546
PubMed: 28857427
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000768
Links to Exploration step
pubmed:28857427Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people.</title>
<author><name sortKey="Shepherd, L" sort="Shepherd, L" uniqKey="Shepherd L" first="L" last="Shepherd">L. Shepherd</name>
<affiliation wicri:level="1"><nlm:affiliation>Research Department of Infection and Population Health, University College London, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Research Department of Infection and Population Health, University College London, London</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Borges, A H" sort="Borges, A H" uniqKey="Borges A" first="Á H" last="Borges">Á H. Borges</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre of Excellence for Health, Immunity and Infections, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Centre of Excellence for Health, Immunity and Infections, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Harvey, R" sort="Harvey, R" uniqKey="Harvey R" first="R" last="Harvey">R. Harvey</name>
<affiliation wicri:level="1"><nlm:affiliation>Charing Cross Oncology Laboratory and Trophoblastic Disease Centre, Charing Cross Hospital Campus of Imperial College Healthcare National Health Service Trust, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Charing Cross Oncology Laboratory and Trophoblastic Disease Centre, Charing Cross Hospital Campus of Imperial College Healthcare National Health Service Trust, London</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bower, M" sort="Bower, M" uniqKey="Bower M" first="M" last="Bower">M. Bower</name>
<affiliation wicri:level="1"><nlm:affiliation>National Centre for HIV Malignancy, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>National Centre for HIV Malignancy, Chelsea and Westminster Hospital NHS Foundation Trust, London</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Grulich, A" sort="Grulich, A" uniqKey="Grulich A" first="A" last="Grulich">A. Grulich</name>
<affiliation wicri:level="1"><nlm:affiliation>Kirby Institute, The University of New South Wales, Sydney, NSW, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Kirby Institute, The University of New South Wales, Sydney, NSW</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Silverberg, M" sort="Silverberg, M" uniqKey="Silverberg M" first="M" last="Silverberg">M. Silverberg</name>
<affiliation wicri:level="1"><nlm:affiliation>Kaiser Permanente Northern California, Oakland, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Weber, J" sort="Weber, J" uniqKey="Weber J" first="J" last="Weber">J. Weber</name>
<affiliation wicri:level="1"><nlm:affiliation>Imperial College London, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Imperial College London, London</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ristola, M" sort="Ristola, M" uniqKey="Ristola M" first="M" last="Ristola">M. Ristola</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Division of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Viard, J P" sort="Viard, J P" uniqKey="Viard J" first="J-P" last="Viard">J-P Viard</name>
<affiliation wicri:level="1"><nlm:affiliation>AP-HP, Diagnostic & Therapeutic Center, Hotel Dieu Hospital, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>AP-HP, Diagnostic & Therapeutic Center, Hotel Dieu Hospital, Paris</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bogner, J R" sort="Bogner, J R" uniqKey="Bogner J" first="J R" last="Bogner">J R Bogner</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine IV, University of Munich, Munich, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Internal Medicine IV, University of Munich, Munich</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Gargalianos Kakolyris, P" sort="Gargalianos Kakolyris, P" uniqKey="Gargalianos Kakolyris P" first="P" last="Gargalianos-Kakolyris">P. Gargalianos-Kakolyris</name>
<affiliation wicri:level="1"><nlm:affiliation>First Department of Internal Medicine and Infectious Diseases Unit, General Hospital of Athens "G. Gennimatas", Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>First Department of Internal Medicine and Infectious Diseases Unit, General Hospital of Athens "G. Gennimatas", Athens</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mussini, C" sort="Mussini, C" uniqKey="Mussini C" first="C" last="Mussini">C. Mussini</name>
<affiliation wicri:level="1"><nlm:affiliation>Clinic of Infectious and Tropical Diseases, University of Modena and Reggio Emilia, Azienda Policlinico, Modena, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Clinic of Infectious and Tropical Diseases, University of Modena and Reggio Emilia, Azienda Policlinico, Modena</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mansinho, K" sort="Mansinho, K" uniqKey="Mansinho K" first="K" last="Mansinho">K. Mansinho</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases, Hospital Egas Moniz-CHLO, E.P.E., Lisboa, Portugal.</nlm:affiliation>
<country xml:lang="fr">Portugal</country>
<wicri:regionArea>Department of Infectious Diseases, Hospital Egas Moniz-CHLO, E.P.E., Lisboa</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Yust, I" sort="Yust, I" uniqKey="Yust I" first="I" last="Yust">I. Yust</name>
<affiliation wicri:level="1"><nlm:affiliation>Ichilov Hospital, Tel Aviv, Israel.</nlm:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Ichilov Hospital, Tel Aviv</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Paduta, D" sort="Paduta, D" uniqKey="Paduta D" first="D" last="Paduta">D. Paduta</name>
<affiliation wicri:level="1"><nlm:affiliation>Gomel Regional Centre for Hygiene, Gomel, Belarus.</nlm:affiliation>
<country xml:lang="fr">Biélorussie</country>
<wicri:regionArea>Gomel Regional Centre for Hygiene, Gomel</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Jilich, D" sort="Jilich, D" uniqKey="Jilich D" first="D" last="Jilich">D. Jilich</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Infectious and Tropical Diseases, First Faculty of Medicine, Charles University, Prague, Czech Republic.</nlm:affiliation>
<country xml:lang="fr">République tchèque</country>
<wicri:regionArea>Department of Infectious and Tropical Diseases, First Faculty of Medicine, Charles University, Prague</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Smiatacz, T" sort="Smiatacz, T" uniqKey="Smiatacz T" first="T" last="Smiatacz">T. Smiatacz</name>
<affiliation wicri:level="1"><nlm:affiliation>Infectious Diseases Department, Medical University of Gdańsk, Gdańsk, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Infectious Diseases Department, Medical University of Gdańsk, Gdańsk</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Radoi, R" sort="Radoi, R" uniqKey="Radoi R" first="R" last="Radoi">R. Radoi</name>
<affiliation wicri:level="1"><nlm:affiliation>Clinical Hospital of Infectious and Tropical Diseases 'Dr. Victor Babeş', Bucharest, Romania.</nlm:affiliation>
<country xml:lang="fr">Roumanie</country>
<wicri:regionArea>Clinical Hospital of Infectious and Tropical Diseases 'Dr. Victor Babeş', Bucharest</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Tomazic, J" sort="Tomazic, J" uniqKey="Tomazic J" first="J" last="Tomazic">J. Tomazic</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia.</nlm:affiliation>
<country xml:lang="fr">Slovénie</country>
<wicri:regionArea>Department of Infectious Diseases, University Medical Center Ljubljana, Ljubljana</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Plomgaard, P" sort="Plomgaard, P" uniqKey="Plomgaard P" first="P" last="Plomgaard">P. Plomgaard</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Department of Clinical Biochemistry, Rigshospitalet, Copenhagen</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Frikke Schmidt, R" sort="Frikke Schmidt, R" uniqKey="Frikke Schmidt R" first="R" last="Frikke-Schmidt">R. Frikke-Schmidt</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Department of Clinical Biochemistry, Rigshospitalet, Copenhagen</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lundgren, J" sort="Lundgren, J" uniqKey="Lundgren J" first="J" last="Lundgren">J. Lundgren</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre of Excellence for Health, Immunity and Infections, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Centre of Excellence for Health, Immunity and Infections, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mocroft, A" sort="Mocroft, A" uniqKey="Mocroft A" first="A" last="Mocroft">A. Mocroft</name>
<affiliation wicri:level="1"><nlm:affiliation>Research Department of Infection and Population Health, University College London, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Research Department of Infection and Population Health, University College London, London</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28857427</idno>
<idno type="pmid">28857427</idno>
<idno type="doi">10.1111/hiv.12546</idno>
<idno type="wicri:Area/PubMed/Corpus">000768</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000768</idno>
<idno type="wicri:Area/PubMed/Curation">000765</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000765</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people.</title>
<author><name sortKey="Shepherd, L" sort="Shepherd, L" uniqKey="Shepherd L" first="L" last="Shepherd">L. Shepherd</name>
<affiliation wicri:level="1"><nlm:affiliation>Research Department of Infection and Population Health, University College London, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Research Department of Infection and Population Health, University College London, London</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Borges, A H" sort="Borges, A H" uniqKey="Borges A" first="Á H" last="Borges">Á H. Borges</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre of Excellence for Health, Immunity and Infections, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Centre of Excellence for Health, Immunity and Infections, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Harvey, R" sort="Harvey, R" uniqKey="Harvey R" first="R" last="Harvey">R. Harvey</name>
<affiliation wicri:level="1"><nlm:affiliation>Charing Cross Oncology Laboratory and Trophoblastic Disease Centre, Charing Cross Hospital Campus of Imperial College Healthcare National Health Service Trust, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Charing Cross Oncology Laboratory and Trophoblastic Disease Centre, Charing Cross Hospital Campus of Imperial College Healthcare National Health Service Trust, London</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bower, M" sort="Bower, M" uniqKey="Bower M" first="M" last="Bower">M. Bower</name>
<affiliation wicri:level="1"><nlm:affiliation>National Centre for HIV Malignancy, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>National Centre for HIV Malignancy, Chelsea and Westminster Hospital NHS Foundation Trust, London</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Grulich, A" sort="Grulich, A" uniqKey="Grulich A" first="A" last="Grulich">A. Grulich</name>
<affiliation wicri:level="1"><nlm:affiliation>Kirby Institute, The University of New South Wales, Sydney, NSW, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Kirby Institute, The University of New South Wales, Sydney, NSW</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Silverberg, M" sort="Silverberg, M" uniqKey="Silverberg M" first="M" last="Silverberg">M. Silverberg</name>
<affiliation wicri:level="1"><nlm:affiliation>Kaiser Permanente Northern California, Oakland, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Kaiser Permanente Northern California, Oakland, CA</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Weber, J" sort="Weber, J" uniqKey="Weber J" first="J" last="Weber">J. Weber</name>
<affiliation wicri:level="1"><nlm:affiliation>Imperial College London, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Imperial College London, London</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ristola, M" sort="Ristola, M" uniqKey="Ristola M" first="M" last="Ristola">M. Ristola</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Division of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Viard, J P" sort="Viard, J P" uniqKey="Viard J" first="J-P" last="Viard">J-P Viard</name>
<affiliation wicri:level="1"><nlm:affiliation>AP-HP, Diagnostic & Therapeutic Center, Hotel Dieu Hospital, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>AP-HP, Diagnostic & Therapeutic Center, Hotel Dieu Hospital, Paris</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bogner, J R" sort="Bogner, J R" uniqKey="Bogner J" first="J R" last="Bogner">J R Bogner</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine IV, University of Munich, Munich, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Internal Medicine IV, University of Munich, Munich</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Gargalianos Kakolyris, P" sort="Gargalianos Kakolyris, P" uniqKey="Gargalianos Kakolyris P" first="P" last="Gargalianos-Kakolyris">P. Gargalianos-Kakolyris</name>
<affiliation wicri:level="1"><nlm:affiliation>First Department of Internal Medicine and Infectious Diseases Unit, General Hospital of Athens "G. Gennimatas", Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>First Department of Internal Medicine and Infectious Diseases Unit, General Hospital of Athens "G. Gennimatas", Athens</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mussini, C" sort="Mussini, C" uniqKey="Mussini C" first="C" last="Mussini">C. Mussini</name>
<affiliation wicri:level="1"><nlm:affiliation>Clinic of Infectious and Tropical Diseases, University of Modena and Reggio Emilia, Azienda Policlinico, Modena, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Clinic of Infectious and Tropical Diseases, University of Modena and Reggio Emilia, Azienda Policlinico, Modena</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mansinho, K" sort="Mansinho, K" uniqKey="Mansinho K" first="K" last="Mansinho">K. Mansinho</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases, Hospital Egas Moniz-CHLO, E.P.E., Lisboa, Portugal.</nlm:affiliation>
<country xml:lang="fr">Portugal</country>
<wicri:regionArea>Department of Infectious Diseases, Hospital Egas Moniz-CHLO, E.P.E., Lisboa</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Yust, I" sort="Yust, I" uniqKey="Yust I" first="I" last="Yust">I. Yust</name>
<affiliation wicri:level="1"><nlm:affiliation>Ichilov Hospital, Tel Aviv, Israel.</nlm:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Ichilov Hospital, Tel Aviv</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Paduta, D" sort="Paduta, D" uniqKey="Paduta D" first="D" last="Paduta">D. Paduta</name>
<affiliation wicri:level="1"><nlm:affiliation>Gomel Regional Centre for Hygiene, Gomel, Belarus.</nlm:affiliation>
<country xml:lang="fr">Biélorussie</country>
<wicri:regionArea>Gomel Regional Centre for Hygiene, Gomel</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Jilich, D" sort="Jilich, D" uniqKey="Jilich D" first="D" last="Jilich">D. Jilich</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Infectious and Tropical Diseases, First Faculty of Medicine, Charles University, Prague, Czech Republic.</nlm:affiliation>
<country xml:lang="fr">République tchèque</country>
<wicri:regionArea>Department of Infectious and Tropical Diseases, First Faculty of Medicine, Charles University, Prague</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Smiatacz, T" sort="Smiatacz, T" uniqKey="Smiatacz T" first="T" last="Smiatacz">T. Smiatacz</name>
<affiliation wicri:level="1"><nlm:affiliation>Infectious Diseases Department, Medical University of Gdańsk, Gdańsk, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Infectious Diseases Department, Medical University of Gdańsk, Gdańsk</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Radoi, R" sort="Radoi, R" uniqKey="Radoi R" first="R" last="Radoi">R. Radoi</name>
<affiliation wicri:level="1"><nlm:affiliation>Clinical Hospital of Infectious and Tropical Diseases 'Dr. Victor Babeş', Bucharest, Romania.</nlm:affiliation>
<country xml:lang="fr">Roumanie</country>
<wicri:regionArea>Clinical Hospital of Infectious and Tropical Diseases 'Dr. Victor Babeş', Bucharest</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Tomazic, J" sort="Tomazic, J" uniqKey="Tomazic J" first="J" last="Tomazic">J. Tomazic</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia.</nlm:affiliation>
<country xml:lang="fr">Slovénie</country>
<wicri:regionArea>Department of Infectious Diseases, University Medical Center Ljubljana, Ljubljana</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Plomgaard, P" sort="Plomgaard, P" uniqKey="Plomgaard P" first="P" last="Plomgaard">P. Plomgaard</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Department of Clinical Biochemistry, Rigshospitalet, Copenhagen</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Frikke Schmidt, R" sort="Frikke Schmidt, R" uniqKey="Frikke Schmidt R" first="R" last="Frikke-Schmidt">R. Frikke-Schmidt</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Department of Clinical Biochemistry, Rigshospitalet, Copenhagen</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lundgren, J" sort="Lundgren, J" uniqKey="Lundgren J" first="J" last="Lundgren">J. Lundgren</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre of Excellence for Health, Immunity and Infections, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</nlm:affiliation>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea>Centre of Excellence for Health, Immunity and Infections, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mocroft, A" sort="Mocroft, A" uniqKey="Mocroft A" first="A" last="Mocroft">A. Mocroft</name>
<affiliation wicri:level="1"><nlm:affiliation>Research Department of Infection and Population Health, University College London, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Research Department of Infection and Population Health, University College London, London</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">HIV medicine</title>
<idno type="eISSN">1468-1293</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">B-cell dysfunction and activation are thought to contribute to lymphoma development in HIV-positive people; however, the mechanisms are not well understood. We investigated levels of several markers of B-cell dysfunction [free light chain (FLC)-κ, FLC-λ, immunoglobulin G (IgG), IgA, IgM and IgD] prior to lymphoma diagnosis in HIV-positive people.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">28857427</PMID>
<DateCreated><Year>2017</Year>
<Month>08</Month>
<Day>31</Day>
</DateCreated>
<DateRevised><Year>2017</Year>
<Month>08</Month>
<Day>31</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-1293</ISSN>
<JournalIssue CitedMedium="Internet"><PubDate><Year>2017</Year>
<Month>Aug</Month>
<Day>31</Day>
</PubDate>
</JournalIssue>
<Title>HIV medicine</Title>
<ISOAbbreviation>HIV Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people.</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/hiv.12546</ELocationID>
<Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">B-cell dysfunction and activation are thought to contribute to lymphoma development in HIV-positive people; however, the mechanisms are not well understood. We investigated levels of several markers of B-cell dysfunction [free light chain (FLC)-κ, FLC-λ, immunoglobulin G (IgG), IgA, IgM and IgD] prior to lymphoma diagnosis in HIV-positive people.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A nested matched case-control study was carried out within the EuroSIDA cohort, including 73 HIV-positive people with lymphoma and 143 HIV-positive lymphoma-free controls. Markers of B-cell dysfunction were measured in prospectively stored serial plasma samples collected before the diagnosis of lymphoma (or selection date in controls). Marker levels ≤ 2 and > 2 years prior to diagnosis were investigated.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Two-fold higher levels of FLC-κ [odds ratio (OR) 1.84; 95% confidence interval (CI) 1.19, 2.84], FLC-λ (OR 2.15; 95% CI 1.34, 3.46), IgG (OR 3.05; 95% CI 1.41, 6.59) and IgM (OR 1.46; 95% CI 1.01, 2.11) were associated with increased risk of lymphoma > 2 years prior to diagnosis, but not ≤ 2 years prior. Despite significant associations > 2 years prior to diagnosis, the predictive accuracy of each marker was poor, with FLC-λ emerging as the strongest candidate with a c-statistic of 0.67 (95% CI 0.58, 0.76).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">FLC-κ, FLC-λ and IgG levels were higher > 2 years before lymphoma diagnosis, suggesting that B-cell dysfunction occurs many years prior to lymphoma development. However, the predictive value of each marker was low and they are unlikely candidates for risk assessment for targeted intervention.</AbstractText>
<CopyrightInformation>© 2017 British HIV Association.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shepherd</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Research Department of Infection and Population Health, University College London, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Borges</LastName>
<ForeName>Á H</ForeName>
<Initials>ÁH</Initials>
<AffiliationInfo><Affiliation>Centre of Excellence for Health, Immunity and Infections, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Harvey</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Charing Cross Oncology Laboratory and Trophoblastic Disease Centre, Charing Cross Hospital Campus of Imperial College Healthcare National Health Service Trust, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bower</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>National Centre for HIV Malignancy, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Grulich</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Kirby Institute, The University of New South Wales, Sydney, NSW, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Silverberg</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Kaiser Permanente Northern California, Oakland, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Weber</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Imperial College London, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ristola</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Division of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Viard</LastName>
<ForeName>J-P</ForeName>
<Initials>JP</Initials>
<AffiliationInfo><Affiliation>AP-HP, Diagnostic & Therapeutic Center, Hotel Dieu Hospital, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bogner</LastName>
<ForeName>J R</ForeName>
<Initials>JR</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine IV, University of Munich, Munich, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gargalianos-Kakolyris</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>First Department of Internal Medicine and Infectious Diseases Unit, General Hospital of Athens "G. Gennimatas", Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mussini</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Clinic of Infectious and Tropical Diseases, University of Modena and Reggio Emilia, Azienda Policlinico, Modena, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mansinho</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>Department of Infectious Diseases, Hospital Egas Moniz-CHLO, E.P.E., Lisboa, Portugal.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yust</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
<AffiliationInfo><Affiliation>Ichilov Hospital, Tel Aviv, Israel.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Paduta</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Gomel Regional Centre for Hygiene, Gomel, Belarus.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Jilich</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Department of Infectious and Tropical Diseases, First Faculty of Medicine, Charles University, Prague, Czech Republic.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Smiatacz</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>Infectious Diseases Department, Medical University of Gdańsk, Gdańsk, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Radoi</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Clinical Hospital of Infectious and Tropical Diseases 'Dr. Victor Babeş', Bucharest, Romania.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tomazic</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Department of Infectious Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Plomgaard</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Frikke-Schmidt</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lundgren</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Centre of Excellence for Health, Immunity and Infections, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mocroft</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Research Department of Infection and Population Health, University College London, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><CollectiveName>EuroSIDA in EuroCOORD</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2017</Year>
<Month>08</Month>
<Day>31</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>HIV Med</MedlineTA>
<NlmUniqueID>100897392</NlmUniqueID>
<ISSNLinking>1464-2662</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HIV</Keyword>
<Keyword MajorTopicYN="N">B-cell dysfunction</Keyword>
<Keyword MajorTopicYN="N">biomarkers</Keyword>
<Keyword MajorTopicYN="N">free light chains</Keyword>
<Keyword MajorTopicYN="N">immunoglobulins</Keyword>
<Keyword MajorTopicYN="N">lymphoma</Keyword>
</KeywordList>
<InvestigatorList><Investigator ValidYN="Y"><LastName>Losso</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kundro</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Schmied</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Karpov</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Vassilenko</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mitsura</LastName>
<ForeName>V M</ForeName>
<Initials>VM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Paduto</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Clumeck</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>De Wit</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Delforge</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Florence</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Vandekerckhove</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Hadziosmanovic</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Begovac</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Machala</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sedlacek</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kronborg</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Benfield</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gerstoft</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Katzenstein</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Møller</LastName>
<ForeName>N F</ForeName>
<Initials>NF</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pedersen</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ostergaard</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Wiese</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Nielsen</LastName>
<ForeName>L N</ForeName>
<Initials>LN</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Zilmer</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Jelena Smidt</LastName>
</Investigator>
<Investigator ValidYN="Y"><LastName>Nakkusosakond Siseklinik</LastName>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kohtla-Järve</LastName>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ristola</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Aho</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Girard</LastName>
<ForeName>P-M</ForeName>
<Initials>PM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pradier</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Fontas</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Duvivier</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Rockstroh</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Schmidt</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Degen</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Stellbrink</LastName>
<ForeName>H J</ForeName>
<Initials>HJ</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Stefan</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Fätkenheuer</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Chkhartishvili</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gargalianos</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Xylomenos</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Armenis</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sambatakou</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Szlávik</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gottfredsson</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mulcahy</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Turner</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Burke</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Shahar</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Hassoun</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Elinav</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Haouzi</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Elbirt</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sthoeger</LastName>
<ForeName>Z M</ForeName>
<Initials>ZM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>D'Arminio Monforte</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Esposito</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mazeu</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mazzotta</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gabbuti</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Vullo</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lichtner</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Zaccarelli</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Antinori</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Acinapura</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Plazzi</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lazzarin</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Castagna</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gianotti</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Galli</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ridolfo</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sacco</LastName>
<ForeName>Osp L</ForeName>
<Initials>OL</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Rozentale</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Uzdaviniene</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Matulionyte</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Staub</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Hemmer</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Reiss</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ormaasen</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Maeland</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Bruun</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Knysz</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gasiorowski</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Inglot</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Horban</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Bakowska</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Flisiak</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Grzeszczuk</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Parczewski</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Maciejewska</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Aksak-Was</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Beniowski</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mularska</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gensing</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Jablonowska</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Malolepsza</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Wojcik</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mozer-Lisewska</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Caldeira</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Maltez</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Oprea</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Victor Babes</LastName>
</Investigator>
<Investigator ValidYN="Y"><LastName>Panteleev</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Panteleev</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Yakovlev</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Trofimora</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Khromova</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kuzovatova</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Borodulina</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Vdoushkina</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Jevtovic</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gatell</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Miró</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Moreno</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Rodriguez</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Clotet</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Jou</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Paredes</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Tural</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Puig</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Bravo</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Domingo</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gutierrez</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mateo</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sambeat</LastName>
<ForeName>M A</ForeName>
<Initials>MA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Laporte</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Falconer</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Thalme</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sonnerborg</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Blaxhult</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Flamholc</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Scherrer</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Weber</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Cavassini</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Calmy</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Furrer</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Battegay</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Schmid</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kuznetsova</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kyselyova</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sluzhynska</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gazzard</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Johnson</LastName>
<ForeName>A M</ForeName>
<Initials>AM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Simons</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Edwards</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Phillips</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Johnson</LastName>
<ForeName>M A</ForeName>
<Initials>MA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mocroft</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Orkin</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Scullard</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Clarke</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Leen</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gatell</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gazzard</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Horban</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Karpov</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Losso</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>d'Arminio Monforte</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pedersen</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Reiss</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Rockstroh</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Rockstroh</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kirk</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kirk</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Peters</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Matthews</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Fischer</LastName>
<ForeName>A H</ForeName>
<Initials>AH</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Bojesen</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Raben</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kristensen</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Grønborg Laut</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Larsen</LastName>
<ForeName>J F</ForeName>
<Initials>JF</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Podlekareva</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Cozzi-Lepri</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Schultze</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Amele</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2017</Year>
<Month>07</Month>
<Day>05</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2017</Year>
<Month>9</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2017</Year>
<Month>9</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>9</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">28857427</ArticleId>
<ArticleId IdType="doi">10.1111/hiv.12546</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000765 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000765 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:28857427 |texte= The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:28857427" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
This area was generated with Dilib version V0.6.33. |